Overweight and obese hypertensive patients can greatly benefit from high adherence rates for lifestyle modifications. The objectives of this paper were to investigate how patients' weight status affected physicians' recommendations of lifestyle modifications and patients' adherence after they received the recommendations. The patients were adults (18 þ years of age) with hypertension (prehypertension, Stage I and Stage II hypertension). The National Health and Nutrition Examination Survey (NHANES) 1999-2000 was used. Weight status was categorized as normal/underweight, overweight and obese. Physicians' recommendations of and patients' adherence to lifestyle modifications (weight control, exercise, sodium intake reduction, alcohol intake reduction) were examined using descriptive and multivariate analyses, controlling for weight status, hypertension stage, comorbidities and demographic characteristics. About 57.0% of the US adult population in 1999-2000 had prehypertension, Stages I or II hypertension. Among the hypertensive adults, 30.3% were normal/underweight, 32.6% were overweight and 37.2% were obese. We found that physicians were more aggressive in recommending lifestyle modification for obese patients. In contrast, obese hypertensive patients were not found to be more likely than normal/underweight patients to adhere to lifestyle modification recommendations. In addition, adherence rates for sodium and alcohol consumption reduction were higher than that for either exercise or weight control. In conclusion, more aggressive approaches should be taken by physicians to educate obese patients about the benefits of lifestyle modifications and to improve adherence to enhance the effects of antihypertensive medications.
Introduction
The JNC 7 and JNC 6 reports repeatedly stress the beneficial effects of nonpharmacological interventions for hypertension. 1, 2 As compared to the adherence to pharmacological treatments, the adherence to nonpharmacological treatments is lower among hypertensive patients. [3] [4] [5] Although it is recommended that physicians provide advice and consultations regarding lifestyle modifications as part of hypertension management, as suggested by the JNC reports, low-to-moderate adherence is observed in hypertensive patients. 6, 7 It was shown that the blood pressure (BP) levels of patients influenced physicians' prescriptions of lifestyle modifications. 6 It is unknown, however, whether a patient's weight status is incorporated in his or her physician's decision of recommending lifestyle modifications. In addition, despite the known benefits of weight control/loss in BP control and management of other chronic conditions and diseases, it is unclear how weight status of a patient influences adherence. Certain patient characteristics, such as age, 8, 9 presence of chronic conditions, education, 9 ethnicity, and income level 10 were found to be associated with adherence to lifestyle modifications. However, whether weight status of a patient was a factor predictive of adherence is not fully understood.
Although one tends to believe that overweight and obese patients would be more likely to be active in improving health, seeking medical care, and adhering to treatment regimens, it was shown that overweight men reported deficits in care as compared with average weight men. 11 Also, a higher body mass index (BMI) increased the likelihood of delay and avoidance of care. 12 In seeking prevention, morbidly obese women were less likely than normal weight women to undergo cancer screenings. 13 Among hypertension patients, results from cluster analyses indicated that obesity and nonadherence to medications were clustered with nonadherence to lifestyle modifications.
14 Unfortunately, no previous studies of chronic disease management investigated the independent effect of patients' weight status on adherence to lifestyle modifications.
The objective of this study was to investigate how weight status affected physicians' recommendations of lifestyle modifications to hypertensive patients and patients' adherence after they received the recommendations. The following hypotheses were tested:
1. Overweight and obese hypertensive patients are more likely than normal weight patients to receive recommendations of lifestyle modifications, given the hypertension stages and comorbidities; and 2. Adherence rates for lifestyle modifications are higher among overweight and obese patients.
Methods

Data
The National Health and Nutrition Examination Survey (NHANES) 1999-2000 was used. 15 This survey was part of the NHANES series starting in the 1960s. The NHANES data were collected by the National Center for Health Statistics (NCHS) at the Centers for Disease Control and Prevention (CDC). The NHANES survey design was a stratified, multistage probability sample of the civilian noninstitutionalized US population. NHANES 1999-2000 oversampled low-income persons, adolescents 12-19 years, persons 60 years of age or older, African Americans and Mexican Americans. In addition to interviews, health examinations were conducted through mobile examination centres, which had on staff one physician, one dentist, two dietary interviewers, three certified medical technologists, five health technicians, one phlebotomist, two interviewers and one computer data manager. Home examinations were given to subjects who were unable or unwilling to visit the mobile examination centres. Laboratory results were obtained from analyses of blood, urine, hair, air, tuberculosis skin test, and household dust specimens collected at the mobile examination centres or in the home. There were 9965 subjects in the NHANES 1999-2000 data set.
Hypertension and weight status
For the purpose of the current study, an adult subject (18 þ years) was included in the sample if (1) his or her systolic blood pressure (SBP) from the examination was 120 mmHg or higher or diastolic blood pressure (DBP) was 80 mmHg or higher, or (2) he or she was taking antihypertensive medications. Three or four BP determinations were taken for each subject in the mobile examination centre or home following standardized protocols. The average readings of the SBP and DBP were used in the current study to determine a subject's hypertension stage. Subjects who satisfied the inclusion criteria were grouped into prehypertension (SBP 120-139 or DBP 80-89 mmHg), Stage I (SBP 140-159 or DBP 90-99 mmHg) and Stage II (SBPX160 or DBPX100 mmHg). 2 In the following text, the definition of hypertension includes prehypertension.
A hypertensive patient's BP may be under control if he or she is taking medications. To incorporate the effects of antihypertensive medications, the final categorization of hypertension status was the interaction of hypertension stage (prehypertension, Stages I and II) and whether a patient took antihypertensives (see the header column of Table 1 ). It should be noted that it is possible for patients who took antihypertensives to have normal BP. Normal BP with antihypertensives was added as an additional category.
Subjects' weight status was determined by their BMI. Body measurements were obtained in the mobile examination centres following the Anthropometric Standardization Reference manual. 16 Using the classification by CDC, subjects were grouped into underweight (BMIo18.5 kg/m 2 ), normal (18.5pBMIo25.0 kg/m 2 ), overweight (25.0pBMIo30.0 kg/m 2 ) and obese (BMIX30.0 kg/ m 2 ). 17 Because the underweight group had too small a sample size to provide accurate estimates, the current study combined the first two groups as the normal/underweight category.
Physicians' recommendations and patients' adherence
In NHANES, subjects were asked 'Have you ever been told by a doctor or other health professional that you had hypertension, also called high blood pressure?' If the answer was 'Yes', then they were further asked whether physicians had recommended lifestyle modifications (LMs). LMs included weight control, reduction of sodium intake, more exercise and reduction of alcohol intake.
Patients' adherence to the recommended LMs were obtained from subjects who received recommendations of LMs from physicians. They were asked (for hypertension) 'Are you now controlling your weight or losing weight', 'Are you now cutting down on salt or sodium in your diet', 'Are you now exercising more', and 'Are you now cutting down on your alcohol consumption,' respectively. Consequently, adherence was defined as responses of 'yes' to these questions.
Control variables
In addition to weight status and hypertension stage, other factors (eg, comorbidities) may have affected physicians' recommendations of LMs. Several control variables in addition to weight status and hypertension status were included in the analyses of the recommendations of LMs. Included selfreported comorbidities were dyslipidaemia, heart diseases, diabetes mellitus, and kidney diseases. Furthermore, patients' age and gender were controlled for. In addition, it has been shown that in predicting adherence, race/ethnicity, educational achievement and income level were significant. [18] [19] [20] In analysing adherence, race/ethnicity, education and income level were also included as control variables.
Statistical analyses
To address how weight status affected physicians' recommendations of LMs, multivariate logistic regressions were used to determine whether physicians took into consideration a patient's weight status in recommending each of the four LMs, controlling for hypertension stage, comorbidities, age and gender of the subject. As discussed earlier, because only patients who were aware of their hypertension responded to the questions of recommendations of LMs, only a subsample of patients (n ¼ 1368) were included in the multivariate analyses. The comparisons between patients who were and were not aware of their hypertension were made.
To examine whether weight status was associated with adherence to each LM, a second set of multivariate logistic regressions were performed, controlling for hypertension stage, comorbidities, age, gender, race/ethnicity, education and income. The adherence analyses were performed among only patients whose physicians recommended LMs, because adherence could not be defined if patients did not receive recommendations from physicians. The complex sampling design, primary sampling units, strata and person weight in NHANES were incorporated in all analyses to provide nationally representative estimates for the adult hypertensive subpopulation. Statistical software STATA s (College Station, TX, USA) was used to perform all analyses.
Results
Among 9965 subjects, 3061 satisfied the criteria of hypertension (including prehypertension), representing 57.0% of the US adult population in 1999-2000. For the hypertensive adult population, about 53.9% were prehypertensive and were not taking antihypertensive medications and about 19.5% were Stages I and II hypertension but not taking antihypertensives. About 4.1 and 10.3% were patients who were taking antihypertensives and had normal BP and prehypertension, respectively. Approximately 12.4% were taking antihypertensives and had Stages I and II hypertension. Among the hypertensive adults, 30.3% were normal/underweight, 32.6% were overweight and 37.2% were obese. The crosstabulation of hypertension stage and weight status of the hypertensive adult population is shown in Table 1 . The general observation was that as compared with normal/underweight patients, overweight and obese patients were more likely to be on antihypertensive medications and more likely to have Stages I and II hypertension. Table 2 reports the composition of the full hypertensive adult sample and the sample of those who were aware of their hypertension to be used in the multivariate analyses. As compared with the full sample, patients who were aware of their hypertension were more likely to be overweight or obese, Effects of obesity on BP management KT Xu and RM Ragain more likely to have chronic comorbidities and older.
All subjects who were not aware of their hypertension were not on antihypertensives (n ¼ 1693) and 70.9% of them had prehypertension. Table 3 shows the descriptive statistics and multivariate analyses of physicians' recommendations of LMs. Over half of the subjects aware of their hypertension were told by their physicians to control weight. About two-thirds were told to reduce sodium consumption and to exercise more. Approximately 28.1% were told to reduce alcohol consumption. As compared to normal/underweight subjects, obese subjects were 9.0 times (Po0.01) as likely to receive advice on weight control, 1.7 times (P ¼ 0.04) as likely to be told by physicians to reduce sodium intake, and more than three times (Po0.01) as likely to be advised to increase exercise levels. The odds of receiving advice on weight control was 2.1 (P ¼ 0.02) among overweight individuals as compared to normal/underweight subjects. Weight status was not found to be associated with recommendations of alcohol intake reduction.
Overall, patients on antihypertensives were significantly more likely than those who were not on antihypertensives to receive all four recommendations from their physicians. Hypertension stage among patients who were not on antihypertensives did not seem to affect the probabilities of receiving the LM recommendations from their physicians.
On the patients' side, a different pattern emerged in regard to the effect of weight status on the adherence to LMs (Table 4) . Among the four LMs, the adherence rate for sodium reduction was the highest, 86.0%, whereas that for more exercise was the lowest, 60.1%. Neither weight status nor hypertension status significantly influenced the adherence. That is, overweight/obese patients were not more likely to adhere to LM recommendations.
Although not shown in Table 4 , a few demographic and health characteristics were found to be associated with adherence. Controlling for weight status and hypertension stage, females were found to be more likely than males to adhere to sodium reduction (OR ¼ 2.46, P ¼ 0.003). Hispanic subjects were more likely than non-Hispanic whites to adhere to recommendations of exercise (OR ¼ 2.61, P ¼ 0.025). Subjects with heart diseases were more likely than those without heart diseases to adhere to recommendations of weight control (OR ¼ 2.42, P ¼ 0.013). Patients with dyslipidaemia were less likely to reduce sodium intake (OR ¼ 0.69, P ¼ 0.031). Diabetic patients were more likely to exercise more (OR ¼ 7.21, Po0.001).
Discussion
This study examined the effects of weight status on whether adult hypertensive patients received recommendations of lifestyle modifications from their physicians and on their adherence. Because overweight and obese patients are at higher risks for elevated BP, we would expect physicians to be more likely to recommend LMs to overweight and obese patients than to normal weight patients, given the same hypertension stage. For the same reason, we would expect overweight and obese patients to be more likely than their normal weight counterparts to adhere to the LM regimens to control BP. Our results indicated that physicians indeed were more aggressive in recommending LMs for obese patients. In contrast, obese hypertensive patients were not Sample size and population proportions that are nationally representative are shown. Complex sampling design of NHANES was incorporated to derive the proportions.
Effects of obesity on BP management KT Xu and RM Ragain The proportions were calculated among subjects who were given recommendations of weight control, sodium reduction, more exercise and alcohol reduction, respectively. Subjects who did not receive the recommendation of a particular lifestyle modification were not included in the analysis of the corresponding lifestyle modification adherence.
Effects of obesity on BP management KT Xu and RM Ragain found to be more likely to adhere to LM recommendations. Summary of the new findings from the current study is shown in Table 5 .
On the patients' side, the current study showed that adherence to sodium and alcohol consumption reduction were greater than that to either exercise or weight control. One possible explanation for the divergence in the adherence rates is that sodium and alcohol consumption reduction require less time and effort than weight control and exercise. The argument of 'ease of execution' has multiple facets in addition to time consumption: the cost, complexity of regimen, behavioural incentives and specificity. Several previous studies have shed some light on these regards. One study noted that cost and transportation contributed to nonadherence to weight control and exercise. 21 In addition, patients' health beliefs may have played an important role. For example, one study demonstrated that greater perceived seriousness of diabetes was associated with greater reduction in BMI at 1 year. 22 Also, a simple recommendation of exercise may not be sufficient to induce behavioural changes because exercise or weight control may be too broad or ambiguous a concept for patients to follow. For instance, in examining exercise in multiple short bouts vs one continuous bout in a randomized trial, researchers found that adherence was significantly greater among subjects who exercised in multiple short bouts per day. 23 One possible explanation for the nonsignificant effect of weight status in predicting adherence is that the actual weight status derived from BMI is not a good measure in explaining adherence behaviours. It may be that how a patient perceives his or her weight status rather than the objective BMI determines adherence behaviour. We performed the same analyses shown in Table 4 , substituting perceived weight status for the objectively measured BMI. The subjects were asked 'Do you consider yourself now to be overweight, underweight, or about the right weight?' Similar results were obtained using the two different measurements of weight status.
The estimated prevalence rate (including prehypertension) was 57.0% among US adults. In contrast, a previous study using the same data calculated a prevalence rate of 28.7%, in which only Stages I and II hypertension were included. 24 Also, because the LM recommendation and adherence data were only available among patients who were aware of their hypertension, we were unable to identify the patterns among subjects who were not aware of their hypertension. As Table 2 shows, the vast majority of the subjects who were unaware of their hypertension had prehypertension and were not using antihypertensives. Consequently, the results from our multivariate analyses were probably more applicable to patients who were on antihypertensives and those with Stages I and II hypertension.
It should be noted that due to the retrospective nature of the study, we were unable to include some factors that may affect adherence, for example, the type of exercise recommended by physicians, the level of alcohol consumption regarded as desirable and whether the subject consulted with a dietitian. Furthermore, self-reported adherence measures were used. Consequently, the measures were subject to possible recall failure and biases associated with certain patient characteristics. Also, for some subjects, BMI may not reflect the true adiposity in the classification of weight status.
In summary, the current study demonstrated that although physicians took into consideration patients' weight status in their recommendations of lifestyle modifications in hypertension management, patients' adherence did not follow this pattern. In particular, obese patients who probably would benefit most from weight control and exercise were not more likely to adhere than normal/underweight patients. More aggressive approaches should be taken by the physicians to educate obese patients about the benefits of lifestyle modifications in Table 5 Summary of the findings Previous studies found enhancing the effects of prescription drugs, their merits of reducing risks of other chronic conditions and diseases, and the importance of self-management of hypertension.
